© Drug Hunter Inc. 2018-2023
Home > Constellation EZH2 inhibitor
long-residence time EZH2 inhibitor
oral efficacy in xenograft model
from optimatization of prior EZH2 inhibitor
"ACS Med. Chem. Lett., Mar. 26, 2020
Constellation Pharma., Cambridge, MA
Constellation EZH2 inhibitor (Constellation oral in vivo long-residence time EZH2 inhibitor)
You don’t have time to read everything, but you can’t afford to fall behind.
Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.
Get ahead now by requesting a trial.
Molecules of the Month
Molecule of the Year